Biocardia, Inc. is a clinical-stage regenerative medicine company focused on developing innovative therapies to address unmet needs in cardiovascular disease. Headquartered in San Carlos, California, Biocardia leverages cutting-edge technologies to advance its product pipeline, which includes cellular therapies and delivery systems aimed at improving patient outcomes. With a commitment to transforming treatments for heart conditions, the company is poised for significant growth as it advances towards key clinical milestones and potential commercialization of its therapies.